Journal of the Korean Ophthalmological Society 2005;46(4):707-715.
Published online April 30, 2005.
Animal Study of Photodynamic Therapy with Verteporfin in Corneal Neovascularization.
Hyeon Ju Nah, Kyung Chul Yoon, Wook Bin Im, Kyu Youn Ahn, Man Seong Seo
1Department of Nursing, Dongkang College, Gwangju, Korea.
2Department of Ophthalmology, Chonnam National University Medical School, Gwangju, Korea. msseo@chonnam.ac.kr
3School of Biological Science and Technology, Chonnam National University, Gwangju, Korea.
4Department of Anatomy, Chonnam National University Medical School, Gwangju, Korea.
각막신생혈관에 대한 버테포르핀을 이용한 광역학치료의 동물실험
나현주1,윤경철2,임욱빈3,안규윤4,서만성2
Department of Nursing, Dongkang College1, Gwangju, Korea, Department of Ophthalmology, Chonnam National University Medical School2, Gwangju, Korea, School of Biological Science & Technology, Chonnam National University3, Gwangju, Korea, Department of Anatomy, Chonnam National University Medical School4, Gwangju, Korea
Correspondence:  Hyeon-Ju Nah, M.N.1
Abstract
PURPOSE
To determine the efficacy of photodynamic therapy (PDT) with verteporfin (Visudyne(R), Norvatis Ophthalmics AG, Hettingen, Switzerland), a benzoporphyrin derivative, in the treatment of corneal neo-vascularization (CN) in a rabbit eye model. METHODS: CN was induced by placing instrastromal sutures in the cornea. Two weeks after suturing, verteporfin was administrated intravenously and 1 hour later, the right eye (treated group) was exposed to a laser with a 689 nm wavelength, and the left eye was used as the control. The changes in CN were analyzed using biomicroscopy and optical microscopy in twelve rabbits. RESULTS: The mean percentages of the neovascular area in the control and treated groups were 96.4 +/- 1.9% and 90.3 +/- 3.5% (P=0.009) at three days after the PDT, 88.6 +/- 4.6% and 71.6 +/- 6.2% (P<0.001) at one week, and 76.8 +/- 4.4% and 43.6 +/- 15.1% (P<0.001) at two weeks, respectively. Optical microscopy showed significant differences between the control and treated group in terms of the area and number of CN (P<0.05). CONCLUSIONS: PDT with verteporfin is a safe and effective procedure for regressing CN. However, a further study will be necessary.
Key Words: Corneal neovascularization;Photodynamic therapy;Verteporfin


ABOUT
BROWSE ARTICLES
EDITORIAL POLICY
FOR CONTRIBUTORS
Editorial Office
SKY 1004 Building #701
50-1 Jungnim-ro, Jung-gu, Seoul 04508, Korea
Tel: +82-2-583-6520    Fax: +82-2-583-6521    E-mail: kos08@ophthalmology.org                

Copyright © 2024 by Korean Ophthalmological Society.

Developed in M2PI

Close layer
prev next